miR-584-5p是一种新的潜在预后生物标志物,用于头部和部状细胞癌
Donghong Yang1, Guanbin Huang1, Haiwen Li1
1Department of Oncology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524000, Guangdong, China.
Current computer-aided drug design
|July 12, 2024
概括
微RNA-584-5p (miR-584-5p) 在头部和部状细胞癌 (HNSC) 中是上调调的,与较差的生存结果相关. 这种微RNA显示出作为HNSC患者治疗标和预后生物标记物的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 微RNA-584-5p (miR-584-5p) 涉及各种癌症,但其在头部和部状细胞癌 (HNSC) 中的具体作用尚不清楚.
- 了解miR-584-5p在HNSC中的功能对于开发向疗法和改善患者治疗结果至关重要.
研究的目的:
- 为了研究miR-584-5p对HNSC的影响.
- 评估miR-584-5p在HNSC中的诊断和预后价值.
- 分析与HNSC.中miR-584-5p相关的目标基因和调控网络.
主要方法:
- 利用癌症基因组图谱 (TCGA) 数据库用于HNSC样本.
- 使用统计分析来评估诊断和预后意义,以及miR-584-5p的临床相关性.
- 进行定量逆转录酶PCR (qRT-PCR) 来确认HNSC细胞系中的miR-584-5p表达.
- 分析了miR-584-5p的目标基因和调控网络.
主要成果:
- 在HNSC中,miR-584-5p的表达在不同类型的癌症中显著变化,并与性别和组织学等级相关.
- 在HNSC患者中,升高的miR-584-5p水平与总生存率,无进展生存率和疾病特异性生存率的降低有关.
- 与正常上皮细胞相比,HNSC细胞系表现出显著更高的miR-584-5p表达,这表明它在癌症中的上调.
结论:
- miR-584-5p在HNSC中表现出独立的预后意义.
- 研究结果表明,miR-584-5p可能会通过包括扩张性和多变性心肌病在内的途径促进HNSC的进展.
- miR-584-5p是HNSC治疗标和预后生物标记物的有希望的候选者.
相关概念视频
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...


